{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:32:01Z","timestamp":1793395921933,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jogc.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Obstetrics and Gynaecology Canada"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jogc.2025.102924","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T19:35:08Z","timestamp":1747337708000},"page":"102924","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Safety of Hydroxyurea in Pregnancy: A Systematic Review of the Literature"],"prefix":"10.1016","volume":"47","author":[{"given":"Ruqaiya","family":"Al Sulaimani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Zitoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hessah","family":"Alothman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine R.","family":"Hutson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8732-247X","authenticated-orcid":false,"given":"Facundo","family":"Garcia-Bournissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogc.2025.102924_bib1","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3390\/ph16060857","article-title":"Effectiveness of pharmacokinetic-guided hydroxyurea dose individualization in patients with sickle cell anemia: a mini-review","volume":"16","author":"Dos Santos Neres","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jogc.2025.102924_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1586\/era.11.175","article-title":"Hydroxyurea: a key player in cancer chemotherapy","volume":"12","author":"Madaan","year":"2012","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.jogc.2025.102924_bib3","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1517\/14740338.2015.1088827","article-title":"Hydroxyurea therapy for sickle cell anemia","volume":"14","author":"McGann","year":"2015","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jogc.2025.102924_bib4","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1365-2141.2005.05583.x","article-title":"The measurement of urinary hydroxyurea in sickle cell anaemia","volume":"130","author":"Dalton","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jogc.2025.102924_bib5","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/ajh.26956","article-title":"An integrated therapeutic approach to sickle cell disease management beyond infancy","volume":"98","author":"Ribeil","year":"2023","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jogc.2025.102924_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30294","article-title":"Efficacy and safety of pharmacological interventions for managing sickle cell disease complications in children and adolescents: systematic review with network meta-analysis","volume":"70","author":"Tonin","year":"2023","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jogc.2025.102924_bib7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/bdrb.20123","article-title":"NTP-CERHR Expert Panel Report on the reproductive and developmental toxicity of hydroxyurea","volume":"80","author":"Liebelt","year":"2007","journal-title":"Birth Defects Research Pt B"},{"key":"10.1016\/j.jogc.2025.102924_bib8","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/cncr.21137","article-title":"Acute leukemia during pregnancy: a report on 37 patients and a review of the literature","volume":"104","author":"Chelghoum","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.jogc.2025.102924_bib9","article-title":"High rate of obstetric complications in patients with essential thrombocythemia","volume":"13","author":"\u0130skender","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.jogc.2025.102924_bib10","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1182\/hematology.2019000039","article-title":"Complications in pregnant women with sickle cell disease","volume":"2019","author":"Smith-Whitley","year":"2019","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jogc.2025.102924_bib11","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1080\/14767058.2020.1786054","article-title":"Management of sickle cell disease during pregnancy: experience in a third-level hospital and future recommendations","volume":"35","author":"Montironi","year":"2022","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.jogc.2025.102924_bib12","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jogc.2025.102924_bib13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/bmjebm-2017-110853","article-title":"Methodological quality and synthesis of case series and case reports","volume":"23","author":"Murad","year":"2018","journal-title":"BMJ Evid Based Med"},{"key":"10.1016\/j.jogc.2025.102924_bib14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.hemonc.2014.03.001","article-title":"Leukemia during pregnancy: long term follow up of 32 cases from a single institution","volume":"7","author":"Saleh","year":"2014","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"10.1016\/j.jogc.2025.102924_bib15","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1080\/01443615.2019.1571024","article-title":"Pregnancy outcomes in women with sickle cell disease: a retrospective study from Eastern India","volume":"39","author":"Patel","year":"2019","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.jogc.2025.102924_bib16","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1038\/sj.leu.2402168","article-title":"Exposure to hydroxyurea during pregnancy: a case series","volume":"15","author":"Thauvin-Robinet","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.jogc.2025.102924_bib17","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/sj.leu.2402494","article-title":"Successful treatment of chronic myeloid leukemia during pregnancy with hydroxyurea","volume":"16","author":"Fadilah","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.jogc.2025.102924_bib18","first-page":"174","article-title":"[Maternal and perinatal outcomes in pregnant women with leukemia]","volume":"33","author":"Nomura","year":"2011","journal-title":"Rev Bras Ginecol Obstet"},{"key":"10.1016\/j.jogc.2025.102924_bib19","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/ajh.26286","article-title":"Real-life experience with hydroxyurea in patients with sickle cell disease: results from the prospective Escort-HU cohort study","volume":"96","author":"de Montalembert","year":"2021","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jogc.2025.102924_bib20","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/ajh.26495","article-title":"Pregnancy outcomes with hydroxyurea use in women with sickle cell disease","volume":"97","author":"Kroner","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jogc.2025.102924_bib21","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1034\/j.1600-0412.2000.079009803.x","article-title":"Hydroxyurea treatment for chronic myeloid leukemia during pregnancy","volume":"79","author":"Celiloglu","year":"2000","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jogc.2025.102924_bib22","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3109\/03630269.2013.828301","article-title":"Perinatal outcome in sickle cell anemia: a prospective study from India","volume":"37","author":"Daigavane","year":"2013","journal-title":"Hemoglobin"},{"key":"10.1016\/j.jogc.2025.102924_bib23","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1034\/j.1600-0609.2001.00367.x","article-title":"A single institutional experience with 43 pregnancies in essential thrombocythemia","volume":"66","author":"Wright","year":"2001","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jogc.2025.102924_bib24","first-page":"1046","article-title":"Exposure to hydroxyurea and pregnancy outcomes in patients with sickle cell anemia","volume":"101","author":"Ballas","year":"2009","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.jogc.2025.102924_bib25","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1080\/10428194.2020.1849672","article-title":"Management of chronic myeloid leukemia during pregnancy among patients treated with a tyrosine kinase inhibitor: a single-Center experience","volume":"62","author":"Assi","year":"2021","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jogc.2025.102924_bib26","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1365-2141.1993.tb08672.x","article-title":"Hydroxyurea treatment for chronic myeloid leukaemia during pregnancy","volume":"85","author":"Jackson","year":"1993","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jogc.2025.102924_bib27","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3390\/biomedicines11020597","article-title":"Outcomes of pregnancy in sickle cell disease patients: results from the prospective Escort-HU cohort study","volume":"11","author":"Habibi","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.jogc.2025.102924_bib28","first-page":"1448","article-title":"The effects of hydroxyurea and related compounds on the rat fetus","volume":"26","author":"Chaube","year":"1966","journal-title":"Cancer Res"},{"key":"10.1016\/j.jogc.2025.102924_bib29","first-page":"174","article-title":"Severe developmental malformations: malformations induced by urethane and hydroxyurea in the hamster","volume":"81","author":"Ferm","year":"1996","journal-title":"Arch Pathol"},{"key":"10.1016\/j.jogc.2025.102924_bib30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/ppe.12417","article-title":"Trends in risk of pregnancy loss among US women, 1990-2011","volume":"32","author":"Rossen","year":"2018","journal-title":"Paediatr Perinat Epidemiol"},{"key":"10.1016\/j.jogc.2025.102924_bib31","article-title":"Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study","volume":"364","author":"Magnus","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jogc.2025.102924_bib32","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2014.028","article-title":"Tyrosine kinase inhibitors and pregnancy","volume":"6","author":"Abruzzese","year":"2014","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.jogc.2025.102924_bib33","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/BF01971445","article-title":"Effects of hydroxyurea on postnatal growth and behaviour of rats","volume":"10","author":"Fritz","year":"1980","journal-title":"Agents Actions"}],"container-title":["Journal of Obstetrics and Gynaecology Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216325001641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216325001641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:40:56Z","timestamp":1764376856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1701216325001641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1701216325001641"],"URL":"https:\/\/doi.org\/10.1016\/j.jogc.2025.102924","relation":{},"ISSN":["1701-2163"],"issn-type":[{"value":"1701-2163","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of Hydroxyurea in Pregnancy: A Systematic Review of the Literature","name":"articletitle","label":"Article Title"},{"value":"Journal of Obstetrics and Gynaecology Canada","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogc.2025.102924","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Society of Obstetricians and Gynaecologists of Canada\/La Soci\u00e9t\u00e9 des obst\u00e9triciens et gyn\u00e9cologues du Canada. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102924"}}